A Phase III Study of TMC435 in Treatment-naive, Genotype 1, Hepatitis C-infected Patients

This study has been completed.

Sponsor:

Information provided by (Responsible Party):

Janssen Pharmaceutical K.K.

ClinicalTrials.gov Identifier:

NCT01292239

First received: February 1, 2011

Last updated: May 10, 2013

Last verified: May 2013

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	October 2012
Primary Completion Date:	October 2012 (Final data collection date for primary outcome measure)
Certification or Request for Extension to Delay Results Received:	April 23, 2013